GSK Industry Innovators - Asthma clinical remission - from inhaled therapies to biologics: can it be achieved?
Monday, March 25, 2024 |
12:10 PM - 12:30 PM |
Theatrette 1 |
Details
Clinical remission is emerging as an important treatment goal for patients with asthma, irrespective of their disease severity and current treatments. In this session, Prof. Peter Gibson (respiratory physician at John Hunter hospital and professor at the University of Newcastle, NSW) will discuss developing frameworks and definitions for asthma remission, further recent evidence on the role of biologics and new evidence on the role of single inhaler triple therapy in attaining on-treatment remission in asthma.
Speaker
Prof Peter Gibson
Doctor
University of Newcastle
Asthma clinical remission - from inhaled therapies to biologics: can it be achieved?
12:10 PM - 12:30 PMBiography
Peter Gibson works as a doctor who cares for people with respiratory diseases and as a clinical scientist investigating the mechanisms and treatment of asthma, COPD, cough, and other airway disorders. He is a concept leader who has developed innovative approaches around inflammatory subtypes of asthma and cough; airway biomarkers; neurogenic mechanisms, laryngeal dysfunction and related treatments for refractory cough; multidimensional assessment and management of complex airway disorders such as severe asthma, airways diseases in the elderly, and asthma in pregnant women.
Peter's research metrics record a H index of 80 (Web of Science), >670 published articles and >$40 Million in research funding. He has had continuous research grant funding from NHMRC, Asthma NSW, MSRP, Cooperative Research Centre for Asthma and Airways and successful NHMRC CRE programmes.
Recognised as Australia’s top pulmonary researcher (The Australian, Research Report 2019) Peter’s peers have awarded him several research honours, including the 2018 ERS Gold Medal in Asthma, and elected him as the president of the Thoracic Society of Australia and New Zealand (2015-6). His research, clinical practice, and participation in guideline panels serve to bring research developments into focus as effective health care interventions that improve the health of people suffering from breathing disorders.
![loading](/Content/Images/loader-large.gif)